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DCCC chromatography followed by HPLC puriﬁcation on the polar extract of marine sponge Theonella
swinhoei resulted in the isolation of ﬁve new cyclopeptides, perthamides GeK. The new structures,
featuring unprecedented amino acid units, were determined by interpretation of extensive spectroscopic
and spectrometric data (MS, 1H and 13C NMR, COSY, HSQC, HMBC, and ROESY). Pharmacological analysis
demonstrated that these natural cyclopeptides are endowed with anti-inﬂammatory potential as as-
sessed by their ability to reduce carrageenan-induced mouse paw oedema.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
Cyclic peptides and cyclodepsipeptides from sponges have been
extensively studied for their signiﬁcant biological activities and
structurally unique features incorporating several modiﬁed amino
acid residues.1,2 Whereas many of these compounds were shown to
be antifungal, antiviral and antiproliferative, few examples of anti-
inﬂammatory peptides from sponges or, more generally, from
marine habitats have so far been reported.3e6
As a part of our systematic study on secondary metabolites
from marine organisms collected at Solomon Islands,7 we found
a single specimen of the sponge Theonella swinhoei as an extraor-
dinary source of new metabolites,8e12 among which were identi-
ﬁed two classes of anti-inﬂammatory peptides, perthamides CeF
(Fig. 1),13e16 and solomonamides.17 Perthamide C (1, Fig. 1), the
most abundant component of the sponge’s polar extracts, is an
octapeptide with an unprecedented primary structure. Six of its
eight residues are non conventional amino acids: g-methylproline,
Nd-carbamoyl-b-OSO3asparagine (Nd-c-b-OHAsn), o-tyrosine, dAbu,
O-methylthreonine, and the b-amino acid AHMHA (3-amino-2-
hydroxy-6-methylheptanoic acid).
From a biological point of view, perthamide C showed promising
anti-inﬂammatory activity measured as a dose-dependentx: þ39 (0)81 678552; e-mail
.it (A. Zampella).
All rights reserved.reduction of mouse carrageenan-induced paw oedema and as
a down-regulation of TNF-a and IL-8 release, two key biomarkers in
the inﬂammatory response of primary human keratinocytes cells.16
In order to re-isolate further amounts of perthamide C for ad-
ditional pharmacological studies, we re-examined the polar ex-
tracts of the sponge T. swinhoei, still available in our laboratories. In
this paper we report the isolation of perthamide C and ﬁve new
minor analogues, perthamides GeK (2e6), whose structures have
been determined by NMR spectroscopy and mass spectrometry
analysis (Fig. 2).2. Results and discussion
The initial processing of the T. swinhoei (coll. No. R3170) was
conducted according to procedures described previously.13 The n-
BuOH extract was puriﬁed by DCCC (n-BuOH/Me2CO/H2O,
descending mode) followed by reverse-phase HPLC using a C-12
column (MeOH/H2O 59% with 0.1% TFA as eluent) to afford 69 mg of
perthamide C (1), 10.8 mg of perthamide G (2), 17.8 mg of pertha-
mide H (3), 16.6 mg of perthamide I (4), 12.2 mg of perthamide J (5),
and 16.2 mg of perthamide K (6).
The HR-ESIMS spectrum of perthamide G (2) showed a major
peak at m/z 1052.4046 [MeNa] corresponding to a molecular
formula C43H62N11NaO18S, 14 u.m.a. less than perthamide C.
Accordingly, comparison of the 1H NMR spectrum of pertha-
mide G (2) with that of parent compound perthamide C (1)
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Fig. 3. Nd-c-b-OHAsn and ADAA residues in perthamides H and J, respectively, with
COSY connectivities (bold bonds) and HMBC correlations (arrows).
C. Festa et al. / Tetrahedron 68 (2012) 2851e28572852showed the absence of the methyl group signal at dH 1.04 assigned
to 3-Me group in the g-MePro residue. One spin system of the type
XeCHeCH2eCH2eCH2eX0 was easily deﬁned using TOCSY, COSY,
HSQC and HMBC data and indicated the presence of one proline
unit. The remaining seven amino acid units were found to be the
same of perthamide C, as suggested by 2D NMR spectroscopic
data.
Marfey’s method revealed L conﬁguration for the Pro residue,
whereas the relative and absolute conﬁguration of L-Asn, L-o-Tyr,
L-ThrOMe, erythro-D-Nd-c-b-OHAsn, (2R,3R)-AHMHA and Z-dAbu,
were determined by comparison of NMR spectroscopic data and
LCeMS analysis of the L/D-FDAA-derivatized hydrolysate of 2with 1.
The molecular formula of perthamide H (3), C44H65N11O15, was
consistent with the lack of the sulfate group in the Nd-carbamoyl-b-
OSO3asparagine residue.
This hypothesis was conﬁrmed by analysis of the NMR spec-
troscopic data. An additional exchangeable proton signal at dH 6.16
(br d, J¼6.4) was observed in the 1H NMR spectrum of perthamide
H (3), and was assigned to the b-OH group in the Nd-c-b-OHAsn
residue on the basis of the COSY spin system NH/H-2/H-3/OH and
the diagnostic HMBC correlations from the hydroxyl proton to C-2,C-3 and C-4 (Fig. 3). The downﬁeld shift exhibited by the NHd
proton (9.52 in 3 vs 8.90 in 1) and C-2 (54.8 in 3 vs 53.0 in 1) and C-4
(173.2 in 3 vs 170.5 in 1) carbons and the upﬁeld shift of H-2, H-3
and C-3 nuclei (Table 1) were all compatible with the presence of
the Nd-c-b-OHAsn residue in 3.The HR-ESIMS of perthamide I (4) showed an ion peak at m/z
1000.4784 [MeH] (m/z 1000.4740, calcd for C45H66N11O15), 14
mass units higher than that of 3. The NMR data for 4 (Table 2)
Table 1
NMR data (700 MHz, DMSO-d6) of perthamide C (1) and perthamides GeH (2 and 3)
Perthamide C (1) Perthamide G (2) Perthamide H (3)
AA dHa dC AA dHa dC AA dHa dC
ThrOMe ThrOMe ThrOMe
1 d 171.0 1 d 171.1 1 d 170.9
2 4.92 d (9.5) 55.3 2 4.93 d (9.3) 55.4 2 4.95 d (9.7) 55.3
3 4.16 ovl 72.8 3 4.15 ovl 73.0 3 4.15 ovl 72.9
4 1.24 d (5.8) 14.3 4 1.23 d (6.0) 14.3 4 1.17 d (6.0) 14.0
OMe 3.27 s 54.7 OMe 3.25 s 54.7 OMe 3.26 s 54.7
NH 9.05 d (8.8) NH 8.94 d (8.2) NH 9.03 d (9.5)
gMePro MePro gMePro
1 d 170.7 1 d 170.9 1 d 170.8
2 3.90 dd (11.0, 6.7) 63.4 2 3.88 dd (9.4, 7.7) 62.9 2 3.89 dd (11.2, 6.6) 63.4
3 0.68e0.74 m,
2.07e2.11 m
36.1 3 1.13 ovl, 2.06e2.11 m 28.2 3 0.68e0.74 m,
2.08e2.11 m
36.1
4 2.29e2.22 m 33.2 4 1.81e1.88 m, 1.93 m 25.1 4 2.22e2.29 m 33.2
5 3.40 t (10.8),
4.11 ovl
53.0 5 3.79e3.85 m,
3.94 t (9.2)
46.8 5 3.40 t (10.8), 4.12 ovl 53.0
6 1.04 d (6.1) 15.9 6 1.04 d (6.4) 15.8
o-Tyr o-Tyr o-Tyr
1 d 170.6 1 d 170.6 1 d 170.7
2 4.12 ovl 56.3 2 4.12 ovl 56.4 2 4.11 ovl 56.4
3 2.86 dd (13.2, 3.2),
2.95 t (13.2)
30.6 3 2.84 dd (13.5, 3.7),
2.94 t (13.5)
30.7 3 2.86 dd (13.2, 3.5),
2.94 t (13.2)
30.6
10 d 124.0 10 d 124.4 10 d 124.3
20 d 154.4 20 d 154.6 20 d 154.5
30 6.88 d (7.8) 114.5 30 6.84 d (8.0) 114.4 30 6.88 d (7.9) 114.5
40 7.11 t (7.8) 127.9 40 7.08 t (8.0) 128.0 40 7.10 t (7.8) 127.9
50 6.80 t (7.4) 119.7 50 6.78 t (7.3) 119.8 50 6.80 t (7.4) 119.8
60 7.16 d (7.4) 130.3 60 7.12 d (7.3) 130.3 60 7.16 d (7.4) 130.4
NH 7.19 ovl NH 7.26 ovl NH 7.22 d (6.7)
OH 10.2 s OH 10.1 s OH 10.2 s
Asn Asn Asn
1 d 170.3 1 d 170.4 1 d 170.5
2 4.68e4.72 m 48.0 2 4.68e4.71 m 48.1 2 4.68e4.72 m 48.0
3 2.41 dd (16.9, 2.2),
3.15 d (16.9)
36.9 3 2.41 dd (17.2, 3.1),
3.10 dd (17.2, 4.3)
36.9 3 2.40 dd (17.5, 2.9),
3.15 dd (17.5, 3.9)
36.9
4 d 172.5 4 d 172.6 4 d 172.4
NH 7.18 ovl NH 7.16 ovl NH 7.18 d (7.1)
NH2 6.51 br s, 7.86 br s NH2 6.51 s, 7.80 s NH2 6.70 br s, 7.82 br s
AHMHA AHMHA AHMHA
1 d 169.7 1 d 169.9 1 d 169.9
2 4.14 ovl 72.6 2 4.14 ovl 72.7 2 4.14 ovl 72.6
3 4.00 t (9.9) 52.0 3 3.98 t (10.2) 51.9 3 3.99 t (9.9) 52.0
4 1.16 ovl, 1.41 ovl 24.1 4 1.14 ovl, 1.39 ovl 24.2 4 1.15 ovl, 1.41 ovl 24.2
5 0.93e0.98 m,
1.15 ovl
34.4 5 0.93e0.98 m, 1.15 ovl 34.3 5 0.93e0.98 m, 1.16 ovl 34.4
6 1.41 ovl 27.2 6 1.40 ovl 27.1 6 1.41 ovl 27.2
7 0.77 d (6.4) 21.9 7 0.76 d (6.6) 21.8 7 0.77 d (6.5) 21.9
8 0.78 d (6.4) 22.2 8 0.77 d (6.6) 22.4 8 0.78 d (6.5) 22.0
NH 6.38 d (9.1) NH 6.40 d (9.5) NH 6.36 d (9.3)
OH 4.81 br s OH 4.81 br s OH 4.83 br s
dAbu dAbu dAbu
1 d 167.2 1 d 167.4 1 d 167.3
2 d 132.1 2 d 132.3 2 d 132.3
3 5.77 q (6.9) 126.4 3 5.75 q (6.8) 126.3 3 5.77 q (6.9) 126.4
4 1.54 d (6.9) 12.1 4 1.55 d (6.8) 12.1 4 1.55 d (6.9) 12.1
NH 8.65 s NH 8.60 s NH 8.68 s
NMeGly NMeGly NMeGly
1 d 167.1 1 d 167.2 1 d 167.3
2 3.31 d (17.9),
4.21 d (17.9)
51.4 2 3.30 ovl, 4.20 d (17.8) 51.4 2 3.36 ovl, 4.25 d (17.4) 51.4
NMe 2.70 s 34.4 NMe 2.70 s 34.5 NMe 2.70 s 34.4
Nd-c-b-OSO3Asn N
d-c-b-OSO3Asn N
d-c-b-OHAsn
1 d 167.4 1 d 167.5 1 d 168.4
2 5.05 t (7.4) 53.0 2 5.03 t (7.4) 53.0 2 4.88 t (7.6) 54.8
3 4.59 d (7.1) 74.9 3 4.58 d (7.1) 74.9 3 4.12 ovl 71.3
4 d 170.5 4 d 170.7 4 d 173.2
bNH 7.18 ovl bNH 7.15 ovl bNH 7.08 d (7.6)
NH 8.90 s NH 8.87 br s NH 9.52 s
CO d n.o CO d n.o CO d n.o
NH2 7.31 br s, 7.51 br s NH2 7.30 br s, 7.50 br s NH2 7.31 br s, 7.51 br s
OH 6.16 br d (6.4)
a Coupling constants are in parentheses and given in hertz. Ovl: overlapped; n.o: not observed. 1H and 13C assignments aided by COSY, TOCSY, HSQC and HMBC experiments.
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C. Festa et al. / Tetrahedron 68 (2012) 2851e28572854closely resembled those of 3 with the exception that resonances
belonging to the b-amino acid AHMHA residue were replaced by
resonances belonging to a 3-amino-2-hydroxy-6-methyloctanoic
acid (AHMOA) unit as in perthamide E.16Table 2
NMR data (700 MHz, DMSO-d6) of perthamides IeK (4e6)
Perthamide I (4) Perthamide J (5)
AA dHa dC AA dHa
ThrOMe ThrOMe
1 d 171.0 1 d
2 4.96 d (9.6) 55.2 2 5.00 dd (1.5
3 4.15 ovl 72.8 3 4.14e4.17 m
4 1.18 d (6.0) 14.3 4 1.14 d (6.1)
OMe 3.27 s 54.7 OMe 3.25 s
NH 9.02 d (9.5) NH 8.99 d (9.7)
gMePro gMePro
1 d 170.9 1 d
2 3.91 dd (11.1, 6.5) 63.1 2 3.86 dd (11.
3 0.71e0.73 m, 2.08e2.14 m 36.2 3 0.68e0.75 m
4 2.22e2.29 m 33.3 4 2.20e2.27 m
5 3.40 t (10.8), 4.12 ovl 53.2 5 3.40 ovl, 4.1
6 1.05 d (6.3) 15.7 6 1.04 d (6.4)
o-Tyr o-Tyr
1 d 170.7 1 d
2 4.11 ovl 56.5 2 4.11 ovl
3 2.89 dd (13.2, 3.6),
2.95 t (13.2)
30.7 3 2.84 dd (13.
2.93 t (13.0)
10 d 124.3 10 d
20 d 154.6 20 d
30 6.88 d (7.9) 114.5 30 6.88 d (8.0)
40 7.11 t (7.8) 128.1 40 7.12 t (8.0)
50 6.80 t (7.4) 119.9 50 6.79 t (7.3)
60 7.18 d (7.4) 130.6 60 7.16 d (7.3)
NH 7.22 d (6.7) NH 7.21 d (6.6)
OH 10.1 s OH 10.2 s
Asn Asn
1 d 170.5 1 d
2 4.68e4.73 m 48.0 2 4.68e4.72 m
3 2.41 dd (17.4, 3.0),
3.15 dd (17.4, 3.9)
36.8 3 2.39 dd (17.
3.18 dd (17.
4 d 172.6 4 d
NH 7.18 d (7.1) NH 7.14 d (7.8)
NH2 6.70 br s, 7.79 br s NH2 6.63 s, 8.02
AHMOA AHMHA
1 d 169.7 1 d
2 4.13 ovl 72.8 2 4.12 ovl
3 4.02 t (9.8) 52.0 3 3.94 t (10.6)
4 1.07e1.11 m, 1.42e1.48 m 23.6 4 1.15 ovl, 1.4
5 1.05 ovl 31.7 5 0.92e0.96 m
6 1.17 ovl 33.3 6 1.40 ovl
7 1.03 ovl, 1.22 ovl 28.5 7 0.76 d (6.5)
8 0.77 t (7.1) 11.1 8 0.77 d (6.5)
9 0.75 d (6.1) 18.6
NH 6.36 d (9.0) NH 6.35 d (9.3)
OH 4.83 br s OH 4.92 s
dAbu dAbu
1 d 167.5 1 d
2 d 132.3 2 d
3 5.78 q (6.9) 126.6 3 5.81 q (6.7)
4 1.56 d (6.9) 11.9 4 1.59 d (7.0)
NH 8.66 s NH 8.69 s
NMeGly NMeGly
1 d 167.2 1 d
2 3.36 ovl, 4.28 d (17.4) 51.6 2 3.53 d (18.0
NMe 2.70 s 34.4 NMe 2.83 s
Nd-c-b-OHAsn ADAA
1 d 168.4 1 d
2 4.89 t (7.7) 54.7 2 5.02 dd (5.5
3 4.12 ovl 71.1 3 5.24 d (3.8)
4 d 173.0 4 d
bNH 7.09 d (7.7) bNH 7.78 d (5.5)
NH 9.48 s NH 12.3 s
CO d n.o CO d
NH2 7.29 br s, 7.52 br s
OH 6.14 br s
a Coupling constants are in parentheses and given in hertz. Ovl: overlapped; n.o: not obLCeMS analysis of the L-FDAA-derivatized hydrolysates of 3 and
4, and the NMR data revealed all a-amino acid residues to possess
conﬁgurations identical to those in 1. On the basis of closely
matching NMR data, the absolute conﬁguration of AHMOA unit in 4Perthamide K (6)
dC AA dHa dC
ThrOMe
171.1 1 d 170.8
, 9.7) 55.5 2 5.01 dd (1.5, 9.7) 55.4
72.6 3 4.16 ovl 72.7
14.1 4 1.15 d (6.2) 14.0
54.9 OMe 3.27 s 54.8
NH 8.99 d (9.7)
gMePro
170.8 1 d 170.7
2, 6.6) 63.5 2 3.91 dd (11.0, 6.6) 63.2
, 2.09e2.13 m 36.1 3 0.63e0.71 m, 2.09e2.13 m 36.0
33.3 4 2.22e2.29 m 33.3
9 dd (10.3, 7.5) 53.0 5 3.40 ovl, 4.18 dd (10.4, 7.6) 52.9
15.8 6 1.04 d (6.2) 15.6
o-Tyr
170.7 1 d 170.5
56.4 2 4.10 ovl 56.2
0, 3.4), 30.5 3 2.87 dd (12.8, 3.4),
2.95 t (12.8)
30.2
124.0 10 d 124.1
154.4 20 d 154.5
114.5 30 6.85 d (8.0) 114.4
128.1 40 7.12 t (8.0) 128.2
119.9 50 6.80 t (7.3) 120.0
130.4 60 7.16 d (7.3) 130.3
NH 7.21 d (6.6)
OH 10.1 s
Asn
170.6 1 d 170.6
47.7 2 4.68e4.74 m 47.7
5, 3.2),
5, 4.2)
36.8 3 2.41 dd (17.6, 3.2),
3.20 dd (17.6, 4.2)
36.6
173.0 4 d 173.1
NH 7.14 d (7.8)
s NH2 6.63 s, 8.00 s
AHMOA
169.4 1 d 169.7
72.4 2 4.14 ovl 72.5
52.2 3 4.01 t (9.7) 51.8
0 ovl 23.8 4 1.07e1.11 m, 1.43e1.49 m 23.7
, 1.17 ovl 34.2 5 1.06 ovl 31.7
27.1 6 1.18 ovl 33.4
21.8 7 1.03 ovl, 1.21 ovl 28.5
22.2 8 0.78 t (7.1) 11.0
9 0.75 d (6.2) 18.6
NH 6.36 d (9.2)
OH 4.82 br s
dAbu
167.3 1 d 167.3
132.2 2 d 132.1
126.4 3 5.81 q (6.6) 126.4
12.1 4 1.56 d (7.0) 12.1
NH 8.68 s
NMeGly
168.3 1 d 168.3
), 4.26 d (18.0) 51.4 2 3.53 d (18.0), 4.26 d (18.0) 51.5
34.9 NMe 2.71 s 34.5
ADAA
166.1 1 d 166.1
, 3.8) 52.5 2 5.05 dd (5.6, 3.7) 52.4
79.5 3 5.22 d (3.7) 79.3
154.9 4 d 154.9
bNH 7.80 d (5.6)
NH 12.3 s
n.o CO d n.o
served. 1H and 13C assignments aided by COSY, TOCSY, HSQC and HMBC experiments.
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Fig. 5. Extract ions of perthamides H (black line), I (red line), J (green line) and K (blue
line) in the LCeESIMS run of crude n-BuOH extract.
C. Festa et al. / Tetrahedron 68 (2012) 2851e2857 2855(Fig. 2) was assumed to be the same as the corresponding residue in
perthamide E (Fig. 1), recently proposed through enantioselective
synthesis14 and quantum chemical calculation of NMR chemical
shifts.16
The HR-ESIMS spectrum of perthamide J (5) showed an ion peak
at m/z 969.4358 [MH], corresponding to a molecular formula of
C44H62N10O15, which is 97 u.m.a. less than perthamide C. NMR data
of perthamide J (5) were almost superimposable to those of parent
peptide, whereas only a perturbation in the Nd-c-b-OSO3Asn resi-
due was observed (Table 2).
In particular in the 1H NMR spectrum the signals relative to the
terminal eNH2 group (7.31/7.51) in the d-carbamoyl moiety were
absent. The downﬁeld shift shown by both the proton and carbon in
thepositionb (dH5.24 vs4.59 in 1; dC 79.5 vs 74.9 in1)was indicative
of an acylation. As shown in Fig. 3, the signal of the NHd, downﬁeld
shifted at dH 12.3 versus 8.90 in perthamide C (1), showed HMBC
correlations with C-3 (dC 79.5) and C-4 (dC 154.9). No further acyl
group could be revealed by analysis of the NMR spectra;18 however
MS data and chemical shift consideration clearly suggested a cycli-
zation between the b-OH group and the carbamoyl moiety to form
a cyclic oxazolidin-2,4-dione. Thus, perthamide J (5) contained the
new 2-amino-2-(2,4-dioxooxazolidin-5-yl)acetic acid residue
(ADAA), replacing the Nd-c-b-OSO3Asn residue in perthamide C.
Comparison by LCeMS of the L/D-FDAA derivatives of the
b-OHAsp residue obtained after acid hydrolysis of 5 with the
corresponding derivatives from the hydrolysate of an authentic
sample of perthamide C (1) showed that the 2-amino-2-(2,4-
dioxooxazolidin-5-yl)acetic acid residue has the same (2R,3S)
conﬁguration as established for the Nd-c-b-OSO3Asn residue in
perthamide C (1) through stereoselective synthesis and Marfey
analysis of all stereoisomers of b-hydroxyaspartate.13
The molecular formula of perthamide K (6), C45H64N10O15, with
an additional methylene group as compared to perthamide J (5),
was deduced by HR-ESIMS, m/z 983.4520 [MeH]. A detailed
analysis of the NMR data of 6 clearly established that its amino acid
sequencewas identical to 5, except for the occurrence of a 3-amino-
2-hydroxy-6-methyloctanoic acid (AHMOA) residue instead of a 3-
amino-2-hydroxy-6-methylheptanoic acid (AHMHA) residue.
Through careful analysis of HMBC and ROESY data, the amino
acid sequence, shown in Fig. 4 for perthamide J (5), was proved in
perthamides G (2), H (3), I (4) and K (6) to be the same as found in 1.NO
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mide J (5).To rule out the suspect of a-biotic origin of perthamides HeK
(3e6) from the parent compounds perthamides C and E during
HPLC isolation procedures in which MeOHeH2O/TFA (0.1%) was
used as the elution solvent, the crude n-BuOH extract of the sponge
was analyzed by LCeESIMS in non-acidic conditions. As shown inFig. 5, the detection of the ions corresponding to the MHþ of per-
thamides H, I, J and K atm/z 988.4, 1002.4, 971.4, 985.4, respectively
(positive ionization mode), in the LCeESIMS run strongly sup-
ported the natural origin of perthamides HeK (3e5).We have previously reported that perthamide C (1) signiﬁcantly
reduced carrageenan-inducedmouse paw oedema in both the early
phase (0e6 h) and the late phase (24e96 h).13 In particular, per-
thamide C (1) displayed a dose-dependent (0.1, 0.3 and 1 mg/kg)
anti-inﬂammatory activity causing about 60% reduction of oedema
development at the dose of 300 mg/kg.13
With this background in mind, we tested all new derivatives in
carrageenan-induced mouse paw oedema. As reported in Fig. 6A,
perthamides H (3), I (4) and K (6) when administered in-
traperitoneally at the dose of 0.3 mg/kg, showed the same behav-
iour as perthamide C (1) reducing mouse oedema in both early
phase (0e6 h) and in the late phase (24e96 h). Notably, Fig. 6B,
perthamide G (2), with a proline replacing the g-methylproline
residue in perthamide C (1), is not endowed with anti-
inﬂammatory activity whereas perthamide J (5), with the ADAA
residue, is the most efﬁcacious molecule of this small library. All
these data pointed towards the pharmacophoric rule played by the
simultaneous presence in the molecule of g-MePro, AHMHA and
ADAA units for anti-inﬂammatory activity.
In conclusion, in this paper we report the isolation and the
structural characterization of ﬁve new perthamide C derivatives,
perthamides GeK (2e6), from the marine sponge T. swinhoei.
Pharmacological analysis demonstrated that these natural cyclo-
peptides are endowedwith anti-inﬂammatory potential as assessed
by their ability to reduce carrageenan-induced mouse paw oedema
and allowed us to delineate a structureeactivity relationship.
3. Experimental section
3.1. General experimental procedures
Speciﬁc rotations weremeasured on a Jasco P-2000 polarimeter.
High-resolution ESIMS spectra were performed on Q-ToF Premiere
A B
Fig. 6. Inhibition on carrageenan-induced paw oedema by perthamide C (1) and perthamides GeK (2e6) at 0.3 mg/kg dose.
C. Festa et al. / Tetrahedron 68 (2012) 2851e28572856(Waters Co.) mass spectrometer. LCeMS experiments were per-
formed on an LCQ Deca (Thermo Scientiﬁc) mass spectrometer
equipped with a FinniganMat quaternary pump. NMR spectra were
obtained on Varian Inova 500 and Varian Inova 700 NMR spec-
trometers (1H at 500 and 700 MHz, 13C at 125 and 175 MHz, re-
spectively) equippedwith Sun hardware, d (ppm), J in hertz, spectra
referred to DMSO-d6 as internal standard (dH 2.50, dC 39.5). HPLC
was performed using a Waters 510 pump equipped with Waters
Rheodine injector and a differential refractometer, model 401.
Through-space 1H connectivities were evidenced using a ROESY
experiment with mixing time of 100 ms.
DCCC was performed using a DCC-A (Rakakikai Co. Di Tokio)
equipped with 250 columns (internal diameter 3 mm).
The purities of compounds were determined to be greater than
95% by HPLC, MS and NMR.3.2. Sponge material and separation of individual peptides
T. swinhoei (order Lithistida, family Theonellidae) was collected
at a depth of 22 m, on an isolated reef off the western coast of
Malaita Island, Solomon Islands, in July 2004. The samples were
frozen immediately after collection and lyophilized to yield 400 g of
dry mass. Taxonomic identiﬁcation was performed by Dr. John
Hooper at Queensland Museum, Brisbane, Australia, where
a voucher specimen is deposited under the accessing number
G322662.
The lyophilized material (400 g) was extracted with methanol
(31.5 L) at room temperature and the crude methanolic extract
was subjected to a modiﬁed Kupchan’s partitioning procedure as
follows. The methanol extract was dissolved in a mixture of MeOH/
H2O containing 10% H2O and partitioned against n-hexane to obtain
15.2 g of the corresponding extract. The water content (% v/v) of the
MeOH extract was adjusted to 30% and partitioned against CHCl3 to
obtain 5.83 g of the corresponding extract. The aqueous phase was
concentrated to remove MeOH and then extracted with n-BuOH to
obtain 6.0 g of the corresponding extract.
The n-BuOH extract (4.0 g) was chromatographed in two runs by
DCCC using n-BuOH/Me2CO/H2O (3:1:5) in the descending mode
(the upper phase was the stationary phase), ﬂow rate 8 mL/min;
4 mL fractions were collected and combined on the basis of their
similar TLC retention factors.
Peptide containing fractions (421.2 mg) were puriﬁed in many
runs by HPLC on a reverse-phase C-12 Jupiter Proteo column
(Phenomenex, 4 m, 2504.6 mm, 1.0 mL/min), eluting in isocratic
mode with 59% MeOH/H2O (0.1% TFA) to afford 10.8 mg of per-
thamide G (2) (tR¼6.3 min), 69.0 mg of perthamide C (1)
(tR¼9.6 min), 17.8 mg of perthamide H (3) (tR¼11.7 min), 12.2 mg
of perthamide J (5) (tR¼12.6 min), 67.8 mg of perthamide E(tR¼14 min), 16.6 mg of perthamide I (4) (tR¼19.5 min) and 16.2 mg
of perthamide K (6) (tR¼20.4 min).
3.3. Characteristic data for each peptide
3.3.1. Perthamide C (1). White amorphous solid; [a]D2287.7 (c 0.87,
CH3OH); 1H and 13C NMR data in DMSO-d6 are given in Table 1; HR-
ESIMS m/z 1066.4106 [MNa] (calcd for C44H64N11O18S m/z
1066.4151).
3.3.2. Perthamide G (2). White amorphous solid; [a]D22 123.3 (c
0.15, CH3OH); 1H and 13C NMR data in DMSO-d6 are given in Table
1; HR-ESIMSm/z 1052.4046 [MNa] (calcd for C43H62N11O18Sm/z
1052.3995).
3.3.3. Perthamide H (3). White amorphous solid; [a]D22 12.9 (c
0.55, CH3OH); 1H and 13C NMR data in DMSO-d6 are given in Table
1; HR-ESIMS m/z 986.4629 [MH] (calcd for C44H64N11O15 m/z
986.4583).
3.3.4. Perthamide I (4). White amorphous solid; [a]D22 119.2 (c
0.13, CH3OH); 1H and 13C NMR data in DMSO-d6 are given in Table
2; HR-ESIMS m/z 1000.4787 [MH] (calcd for C45H66N11O15 m/z
1000.4740).
3.3.5. Perthamide J (5). White amorphous solid; [a]D22 þ227.7 (c
0.26, CH3OH); 1H and 13C NMR data in DMSO-d6 are given in Table
2; HR-ESIMS m/z 969.4358 [MH] (calcd for C44H61N10O15 m/z
969.4318).
3.3.6. Perthamide K (6). White amorphous solid; [a]D22 74.9 (c
0.37, CH3OH); 1H and 13C NMR data in DMSO-d6 are given in Table
2; HR-ESIMS m/z 983.4520 [MH] (calcd for C45H63N10O15 m/z
983.4474).
3.4. Determination of amino acid absolute conﬁguration
Perthamides C, E and GeK (500 mg) were dissolved, in four
evacuated glass tubes, in 6 N aq HCl (0.5 mL) and heated at 160 C
for 3 h. The solvent was removed in vacuo and the resulting ma-
terial was subjected to further derivatisation.
A portion of the hydrolysate mixture (300 mg) was dissolved in
a solution of TEA/MeCN (2:3, 80 mL) and this solution was then
treated with 1-ﬂuoro-2,4-dinitrophenyl-5-L-alaninamide (L-FDAA)
in 1:2 MeCN/Me2CO (1% solution, 75 mL). The vials were heated at
70 C for 1 h, and the contents were neutralised with 0.2 N aq HCl
(50 mL) after cooling to room temperature. An aliquot of the L-FDAA
derivative was dried under vacuum, diluted with MeCN/5% HCOOH
C. Festa et al. / Tetrahedron 68 (2012) 2851e2857 2857in H2O (1:1) and separated on a Jupiter C18 (154.60) by means of
a linear gradient from 10% to 50% aq MeCN containing 5% formic
acid and 0.05% triﬂuoroacetic acid, over 45 min at 0.15 mL/min. The
RP-HPLC system was connected to the electrospray ion source by
inserting a splitter valve and the ﬂow going into the mass spec-
trometer sourcewas set at a value of 100 mL/min. Mass spectrawere
acquired in positive ion detection mode (m/z interval of 320e900)
and the datawere analyzed using the suite of programs Xcalibur; all
masses were reported as average values. The capillary temperature
was set at 280 C, capillary voltage at 37 V, tube lens offset at 50 V
and ion spray voltage at 5 V.
To determine the absolute conﬁguration of Pro residue in per-
thamide G (2), authentic samples of Pro were used as standard.
Retention times of L-FDAA-derivatized prolines: L-Pro (17.14 min)
and D-Pro (18.76 min). Perthamide G (2) contains L-Pro (17.16 min).
All FDAA derivatives of amino acid residues in perthamides H (3)
and I (4) were co-eluted with the corresponding ones in pertha-
mides C and E.13
To determine the absolute conﬁguration of 2-amino-2-(2,4-
dioxooxazolidin-5-yl)acetic acid residue (ADAA) in perthamides J
(5) and K (6), an authentic sample of perthamide C was used as
a standard.
Perthamide C (1) contained (2R,3S)-b-OHAsp (10.20 min). Per-
thamides J and K contained (2R,3S)-b-OHAsp (10.02 min).3.5. LCeMS on the crude n-BuOH extract
An aliquot of the crude n-BuOH extract was dried under vac-
uum, diluted with MeCN and separated on a Jupiter C18 column
(251.8 mm i.d.) by means of a linear gradient from 10% to 95% aq
MeCN containing 10 mM of ammonium acetate, over 45 min at
0.15 mL/min. The RP-HPLC system was connected to the electro-
spray ion source by inserting a splitter valve and the ﬂowgoing into
the mass spectrometer source was set at a value of 100 mL/min.
Mass spectra were acquired in positive ion detection mode (m/z
interval of 950e1200) and the datawere analyzed using the suite of
programs Xcalibur; all masses were reported as average values. The
capillary temperature was set at 280 C, capillary voltage at 37 V,
tube lens offset at 50 V and ion spray voltage at 5 V.3.6. Carrageenan-induced mouse paw oedema
Male Swiss mice (CD-1; Harlan, Italy) weighing 28e30 g were
separated in groups (n¼6) and lightly anaesthetized with iso-
ﬂurane. Each group of animals received subplantar injection of
50 mL of carrageenan 1% (w/v) or saline into the left footpad.19 Paw
volume was measured by using an hydropletismometer specially
modiﬁed for small volumes (Ugo Basile, Comerio, Italy) immedi-
ately before the subplantar injection and 2, 4, 6, 24, 48, 72 and 96 h
thereafter. The same operator always performed the double-blind
assessment of paw volume. The increase in paw volume was eval-
uated as the difference between the paw volume at each time point
and the basal paw volume. Each group of animals received in-
traperitoneal administration of compounds 1, 2, 3, 4, 5, 6 (0.3 mg/kg, 100 mL) or vehicle (PEG). All compounds were administrated
immediately before carrageenan injection and 24 h thereafter.
3.7. Statistical analysis
Results were expressed as meanSEM. Statistical analysis was
determined by one way ANOVA followed by Dunnett’s test for
multiple comparisons, using GraphPad Prism software (GraphPad
Software Inc., San Diego, CA). Differences were considered statis-
tically signiﬁcant when p was less than 0.05.
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